ClinicalTrials.gov
ClinicalTrials.gov Menu

Novel Therapies for Metabolic Complications of Lipodystrophies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00457938
Recruitment Status : Unknown
Verified June 2013 by Abhimanyu Garg, University of Texas Southwestern Medical Center.
Recruitment status was:  Recruiting
First Posted : April 9, 2007
Last Update Posted : June 21, 2013
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Takeda
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : August 2016
  Estimated Study Completion Date : December 2016